Association of Chronic @entity120 with Hereditary and Acquired Risk Factors for XXXX .

@entity1 @entity556 @entity120 @entity49 @entity1151 @entity1031 @entity715
UNASSIGNED: @entity49 increases the incidence of @entity715 significantly. Various hereditary and acquired factors are known for @entity1031 . The hereditary factors are two common genetic autosomal mutations including factor V leidan mutation and @entity556 gene mutation. A descriptive- analytical design was conducted on 60 @entity1 with @entity1031 who met the inclusion criteria. Two groups with hereditary and acquired risk factors for @entity1031 (group A, B, each 30 @entity1 ) were evaluated. All the @entity1 of two groups were evaluated in terms of emboli associated with hereditary and acquired risk factors. Association of @entity1031 risk factors' with @entity120 were studied at the beginning of the study and six months after the treatment then the results of two groups were compared. Among @entity1 , 31 (56.4%) were @entity1 .   The mean age of the @entity1 was 44.4  14 years, ranging between 23-75 years. Significant association was observed between the stability of the blood clot in pulmonary vessel, six months after the treatment with genetic risk factors (P=0.03). However, no significant association was between @entity120 and hereditary and acquired risk factors (P=0.24). Based on the significant association between the hereditary risk factors and @entity1151 , by taking special prevention and therapy measurements (e.g. genetic engineering), some pulmonary and mortality complications can be prevented and the @entity1 himself and health care system would benefit from this issue.
